CU23884B1 - Derivados de dibenzotiazepina - Google Patents

Derivados de dibenzotiazepina

Info

Publication number
CU23884B1
CU23884B1 CU20100252A CU20100252A CU23884B1 CU 23884 B1 CU23884 B1 CU 23884B1 CU 20100252 A CU20100252 A CU 20100252A CU 20100252 A CU20100252 A CU 20100252A CU 23884 B1 CU23884 B1 CU 23884B1
Authority
CU
Cuba
Prior art keywords
dibenzotiazepina
derivatives
Prior art date
Application number
CU20100252A
Other languages
English (en)
Spanish (es)
Other versions
CU20100252A7 (es
Inventor
Dean Brown
James R Damewood
Phil Edwards
James Hulsizer
James Campbell Muir
Jr M Edward Pearson
Ashokkumar Bhikkappa Shenvi
Steven Wesolowski
Dan Widzowski
Michael Wood
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41431860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU23884(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CU20100252A7 publication Critical patent/CU20100252A7/es
Publication of CU23884B1 publication Critical patent/CU23884B1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
CU20100252A 2008-06-20 2010-12-20 Derivados de dibenzotiazepina CU23884B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7441708P 2008-06-20 2008-06-20
PCT/SE2009/050763 WO2009154563A1 (en) 2008-06-20 2009-06-18 Dibenzothiazepine derivatives and use thereof

Publications (2)

Publication Number Publication Date
CU20100252A7 CU20100252A7 (es) 2011-11-15
CU23884B1 true CU23884B1 (es) 2013-04-19

Family

ID=41431860

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20100252A CU23884B1 (es) 2008-06-20 2010-12-20 Derivados de dibenzotiazepina

Country Status (37)

Country Link
US (3) US20110160184A1 (me)
EP (1) EP2307389B1 (me)
JP (2) JP5468068B2 (me)
KR (1) KR20110019781A (me)
CN (1) CN102131791B (me)
AR (1) AR072200A1 (me)
AU (1) AU2009260905B2 (me)
BR (1) BRPI0914231A2 (me)
CA (1) CA2728675A1 (me)
CL (1) CL2010001471A1 (me)
CR (1) CR11860A (me)
CU (1) CU23884B1 (me)
CY (1) CY1113845T1 (me)
DK (1) DK2307389T3 (me)
DO (1) DOP2010000393A (me)
EA (1) EA201001889A1 (me)
EC (1) ECSP10010698A (me)
ES (1) ES2402084T3 (me)
HN (1) HN2010002683A (me)
HR (1) HRP20130234T1 (me)
IL (2) IL210081A (me)
ME (1) ME01516B (me)
MX (1) MX2010014203A (me)
MY (1) MY157518A (me)
NI (1) NI201000224A (me)
NZ (1) NZ590616A (me)
PE (1) PE20110029A1 (me)
PL (1) PL2307389T3 (me)
PT (1) PT2307389E (me)
RS (1) RS52703B (me)
SI (1) SI2307389T1 (me)
SV (1) SV2010003769A (me)
TW (1) TWI488854B (me)
UA (1) UA105903C2 (me)
UY (1) UY31919A (me)
WO (1) WO2009154563A1 (me)
ZA (1) ZA201100488B (me)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102131791B (zh) * 2008-06-20 2014-12-24 阿斯利康(瑞典)有限公司 二苯并硫杂氮杂*衍生物及其用途
CN105981027A (zh) * 2013-08-12 2016-09-28 哥莱菲特软件公司 安全认证并切换至加密域
CN103524455A (zh) * 2013-10-30 2014-01-22 苏州敬业医药化工有限公司 一种制备2-氯-二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮的方法
CA2931289C (en) 2013-11-21 2023-10-17 Graphite Software Corporation Managed domains for remote content and configuration control on mobile information devices
CN104447615A (zh) * 2014-02-28 2015-03-25 广东东阳光药业有限公司 喹硫平中间体的制备方法
EP4428132A1 (en) * 2023-03-08 2024-09-11 Johann-Wolfgang-Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use
JP2026509430A (ja) * 2023-03-08 2026-03-19 ヨハン ヴォルフガング ゲーテ－ウニベルジテート フランクフルト アム マイン Ｓｌａｃｋ活性化化合物及びその医学的用途

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL293201A (me)
NL294355A (me)
DE1620703B2 (de) * 1960-08-16 1976-11-25 Ausscheidung aus: 12 80 879 Dr. A. Wander AG, Bern 11-basisch substituierte dibenzo eckige klammer auf b,f eckige klammer zu-eckige klammer auf 1,4 eckige klammer zu-thiazepine
CH422793A (de) 1961-07-20 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine
CH476753A (de) 1962-06-08 1969-08-15 Wander Ag Dr A Verfahren zur Herstellung von 11-basisch substituierter Dibenzo(b,f)(1,4)thiazepine
DE1470416A1 (de) 1962-05-25 1969-05-14 Wander Ag Dr A Verfahren zur Herstellung ll-basisch substituierter 5 H-Dibenzo[b,e],[1,4] diazepine
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
NL293210A (me) 1963-05-09
US3884920A (en) 1967-07-14 1975-05-20 Sandoz Ag 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines
US3683034A (en) 1963-09-27 1972-08-08 Upjohn Co Process for the preparation of substituted hydroquinones
US3908010A (en) 1967-03-22 1975-09-23 Wander Ag Dr A Basically substituted heterocycles as anti-emetics
US3412193A (en) 1965-12-13 1968-11-19 American Cyanamid Co 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility
AT278805B (de) 1966-01-17 1970-02-10 American Cyanamid Co Verfahren zur herstellung von oxazepinen und thiazepinen
NL6715650A (me) 1966-12-16 1968-06-17
US3852446A (en) 1967-03-13 1974-12-03 Sandoz Ag Organic compounds in treatment of psychotic disturbances
US3758479A (en) 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
US3539573A (en) 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
CH569731A5 (me) * 1972-04-04 1975-11-28 Wander Ag Dr A
GB8607684D0 (en) 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
JPH04211071A (ja) * 1990-03-05 1992-08-03 Hokuriku Seiyaku Co Ltd 多環式化合物
JPH0565257A (ja) 1991-07-05 1993-03-19 Hokuriku Seiyaku Co Ltd 多環式化合物及びその用途
US5750566A (en) 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids
ATE192157T1 (de) 1994-08-24 2000-05-15 Astra Ab Therapeutisch verwendbare spiro-azabicyclische verbindungen
US5602121A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
WO2000010572A1 (en) 1998-08-18 2000-03-02 Sepracor Inc. Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
SE9900100D0 (sv) 1999-01-15 1999-01-15 Astra Ab New compounds
WO2001008680A1 (de) 1999-07-28 2001-02-08 Oswald Wiss Präparate mit sauerstoffsparender wirkung bei körperlicher leistung
SE9903760D0 (sv) 1999-10-18 1999-10-18 Astra Ab New compounds
SE0002729D0 (sv) 2000-07-20 2000-07-20 Astrazeneca Ab Novel compound form
US6630462B2 (en) 2000-11-17 2003-10-07 Adolor Corporation Delta agonist analgesics
IL139975A0 (en) 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
PT1395567E (pt) 2001-05-18 2009-03-26 Astrazeneca Ab Derivados de 4(fenil-piperazinil-metil)benzamida e sua utilização para o tratamento da ansiedade da dor ou de distúrbios gastrointestinais
BR0210075A (pt) 2001-06-01 2004-08-17 Astrazeneca Ab Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa
HRP20040102A2 (en) 2001-07-09 2004-10-31 Combinatorx Combinations for the treatment of inflammatory disorders
ES2379544T3 (es) 2001-09-27 2012-04-27 Ramot At Tel Aviv University Ltd. Conjugado de perfenazina y GABA y usos del mismo
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
ES2348282T3 (es) 2002-04-18 2010-12-02 Astrazeneca Ab Compuestos de tienilo.
US7417049B2 (en) 2002-04-18 2008-08-26 Astrazeneca Ab Furyl compounds
NZ561993A (en) 2002-04-18 2008-09-26 Astrazeneca Ab Spiroazabicyclic heterocyclic amines as potent ligands for nicotinic acetylcholine receptors
SE0202430D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
SE0202465D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
SE0202598D0 (sv) 2002-09-02 2002-09-02 Astrazeneca Ab Alpha-7 Nicotinic receptor agonists and statins in combination
EP1538906A2 (en) 2002-09-18 2005-06-15 Fmc Corporation Insecticidal tricyclic derivatives
JP2006510697A (ja) * 2002-12-20 2006-03-30 ビーエーエスエフ　アクチェンゲゼルシャフト 殺虫性ジベンゾ（ヘテロ）アゼピン誘導体
JP2006515628A (ja) 2003-01-23 2006-06-01 アカディア ファーマシューティカルズ，インコーポレーテッド ヒト神経精神疾患を処置するためのｎ−デスメチルクロザピンの使用
CN1777594A (zh) 2003-02-22 2006-05-24 特瓦制药工业有限公司 喹迪平及其可药用盐的合成
DE10310196A1 (de) 2003-03-06 2004-09-23 Rina-Netzwerk Rna Technologien Gmbh Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose
DE602004012083T2 (de) 2003-04-15 2009-04-23 Astrazeneca Ab Neue Verbindungen, die als Verstärker von Glutamatrezeptoren dienen
US20060217366A1 (en) * 2003-07-02 2006-09-28 Astrazeneca Ab Method of treating schizophrenia and other disorders
PL195728B1 (pl) 2003-07-18 2007-10-31 Helm Ag Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny
RU2394030C2 (ru) * 2003-12-22 2010-07-10 Акадиа Фармасьютикалз Инк. АМИНОЗАМЕЩЕННЫЕ АНАЛОГИ ДИАРИЛ [a,d] ЦИКЛОГЕПТЕНА В КАЧЕСТВЕ МУСКАРИНОВЫХ АГОНИСТОВ И СПОСОБЫ ЛЕЧЕНИЯ ПСИХОНЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ
PT1696931E (pt) * 2003-12-22 2009-06-12 Acadia Pharm Inc Análogos diaril[a,d]ciclo-hepteno substituídos com amino utilizados como agonistas muscarínicos e métodos de tratamento de perturbações neuropsiquiátricas
US20060063754A1 (en) * 2004-09-21 2006-03-23 Edgar Dale M Methods of treating a sleep disorder
JP2008525478A (ja) 2004-12-27 2008-07-17 アストラゼネカ アクチボラグ 神経系及び精神医学系障害の治療のための代謝共役型グルタミン酸受容体アゴニストとしてのピラゾロン化合物
JP2008526839A (ja) * 2005-01-07 2008-07-24 アストラゼネカ・アクチエボラーグ １１−ピペラジン−１−イルジベンゾ［ｂ，ｆ］［１，４］チアゼピン又はその薬学的に許容される塩の新規な使用及び経口医薬組成物への新規な使用
AU2006231497A1 (en) * 2005-04-04 2006-10-12 Acadia Pharmaceuticals Inc. Use of N-desmethylclozapine and related compounds as dopamine stabilizing agents
WO2007053618A1 (en) * 2005-10-31 2007-05-10 Acadia Pharmaceuticals Inc. Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
EP2099459A4 (en) 2006-12-20 2011-04-27 Astrazeneca Ab COMPOUNDS AND USES THEREOF
EP2114940A1 (en) 2007-02-09 2009-11-11 AstraZeneca AB Aza-isoindolones and their use as metabotropic glutamate receptor potentiators - 613
US7491871B2 (en) 2007-04-25 2009-02-17 Stine Seed Farm, Inc. Soybean cultivar S060299
TWI417100B (zh) 2007-06-07 2013-12-01 Astrazeneca Ab 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
TW200911255A (en) 2007-06-07 2009-03-16 Astrazeneca Ab Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
CN102131791B (zh) * 2008-06-20 2014-12-24 阿斯利康(瑞典)有限公司 二苯并硫杂氮杂*衍生物及其用途

Also Published As

Publication number Publication date
AR072200A1 (es) 2010-08-11
TW201002702A (en) 2010-01-16
ZA201100488B (en) 2011-10-26
ECSP10010698A (es) 2011-01-31
JP2014098006A (ja) 2014-05-29
AU2009260905B2 (en) 2012-08-23
IL210081A0 (en) 2011-02-28
CN102131791B (zh) 2014-12-24
DK2307389T3 (da) 2013-04-02
SI2307389T1 (sl) 2013-04-30
US20110160184A1 (en) 2011-06-30
CL2010001471A1 (es) 2011-05-06
JP2011524898A (ja) 2011-09-08
JP5468068B2 (ja) 2014-04-09
PE20110029A1 (es) 2011-02-11
PT2307389E (pt) 2013-03-28
EP2307389A1 (en) 2011-04-13
EA201001889A1 (ru) 2011-08-30
MX2010014203A (es) 2011-02-22
DOP2010000393A (es) 2011-01-31
HN2010002683A (es) 2013-01-15
ME01516B (me) 2014-04-20
US8653257B2 (en) 2014-02-18
RS52703B (sr) 2013-08-30
HK1156308A1 (en) 2012-06-08
CN102131791A (zh) 2011-07-20
CR11860A (es) 2011-02-25
CA2728675A1 (en) 2009-12-23
EP2307389A4 (en) 2012-04-11
IL229560A (en) 2015-07-30
CY1113845T1 (el) 2016-07-27
MY157518A (en) 2016-06-15
IL210081A (en) 2013-12-31
US8158618B2 (en) 2012-04-17
BRPI0914231A2 (pt) 2015-11-03
ES2402084T3 (es) 2013-04-26
EP2307389B1 (en) 2013-01-23
KR20110019781A (ko) 2011-02-28
UY31919A (es) 2010-01-29
HRP20130234T1 (hr) 2013-04-30
CU20100252A7 (es) 2011-11-15
NI201000224A (es) 2012-03-19
WO2009154563A1 (en) 2009-12-23
US20090318415A1 (en) 2009-12-24
IL229560A0 (en) 2014-01-30
TWI488854B (zh) 2015-06-21
PL2307389T3 (pl) 2013-05-31
AU2009260905A1 (en) 2009-12-23
SV2010003769A (es) 2011-05-20
NZ590616A (en) 2012-09-28
UA105903C2 (uk) 2014-07-10
US20120202991A1 (en) 2012-08-09

Similar Documents

Publication Publication Date Title
DK2308877T3 (da) Imidazopyridin-2-on-derivater
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
BRPI0915064A2 (pt) derivados de qunoxalinadiona
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
ECSP12011999A (es) Derivados benzamida sustituidos
EP2376493A4 (en) DIHYDROPYRIMIDOPYRIMIDINDERIVAT
EP2380877A4 (en) PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
EP2462134A4 (en) N1-sulfonyl-5-FLUORPYRIMIDINON DERIVATIVES
BR112012015868A2 (pt) derivados de imidazolidinadiona
HRP20150477T8 (hr) Postupci dobivanja derivata kinazolona
EP2124523A4 (en) BREEDING LINE P2428-5006090
BRPI1013844A2 (pt) derivados de piridina-isoxazol
EP2433940A4 (en) SPIROIMIDAZOLONDERIVAT
DK2397480T3 (da) Diazepindionderivat
EP2336132A4 (en) MORPHOLINPURINDERIVAT
CR10562A (es) Nuevos derivados de piridazina
DK2275414T3 (da) Cyclopentylacrylamidderivat
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
EP2349335A4 (en) LEVETIRACETAM IMMUNOASSAYS
ATE545635T1 (de) Substituierte n-oxidpyrazinderivate
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI0922652A2 (pt) Derivados de quinazolinamida

Legal Events

Date Code Title Description
FG Grant of patent
FD Lapse (for not paying fees)